Zhengye Biotechnology Holding Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ZYBT research report →
Companywww.jlzybio.com
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt.
- CEO
- Songlin Song
- IPO
- 2025
- Employees
- 278
- HQ
- Jilin, CN
Price Chart
Valuation
- Market Cap
- $42.06M
- P/E
- 0.00
- P/S
- 2.46
- P/B
- 0.00
- EV/EBITDA
- -7.31
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 20.51%
- Op Margin
- -58.66%
- Net Margin
- -59.97%
- ROE
- -26.15%
- ROIC
- -17.87%
Growth & Income
- Revenue
- $116.36M · -37.56%
- Net Income
- $-69,784,000 · -716.96%
- EPS
- $0.00 · -100.00%
- Op Income
- $-68,254,000
- FCF YoY
- -94.70%
Performance & Tape
- 52W High
- $13.08
- 52W Low
- $0.68
- 50D MA
- $0.93
- 200D MA
- $2.69
- Beta
- -2.45
- Avg Volume
- 229.13K
Get TickerSpark's AI analysis on ZYBT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 24, 26 | Hu Qiyi | other | 0 |
| Mar 24, 26 | Li Guohan (nmn) | other | 0 |
| Mar 18, 26 | Liu Zhongyao | other | 0 |
| Mar 18, 26 | Sun Wenhua | other | 0 |
| Mar 18, 26 | Lian Wei | other | 0 |
| Mar 18, 26 | Han Aiden | other | 0 |
Our ZYBT Coverage
We haven't published any research on ZYBT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ZYBT Report →